TRPC1 Antibodies

Santa Cruz Biotechnology features a diverse variety of TRPC1 monoclonal antibodies for research focused on understanding TRPC1 protein function. TRPC1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).TRPC1, or Transient Receptor Potential Cation Channel 1, is a critical component in cellular signaling pathways, particularly in the regulation of calcium influx and cellular excitability. TRPC1 plays a significant role in various physiological processes, including smooth muscle contraction, neuronal signaling, and the modulation of immune responses. Understanding TRPC1 function is essential for elucidating its involvement in pathophysiological conditions, such as cardiovascular diseases and neurodegenerative disorders. Research has shown that TRPC1 expression levels can vary significantly across different tissue types and developmental stages. TRPC1 has been identified as a potential therapeutic target in multiple disease states. Recent studies have highlighted TRPC1's role in cellular calcium homeostasis and membrane potential regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of TRPC1's role in human health and disease.